68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study

68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients

(2023) Shan Zheng et al.   CLINICAL NUCLEAR MEDICINE

Initial Results of FAPI-PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer

(2022) Philipp Backhaus et al.   JOURNAL OF NUCLEAR MEDICINE

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

(2021) Larissa A. Korde et al.   JOURNAL OF CLINICAL ONCOLOGY

68Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET/CT

(2021) Halil Kömek et al.   ANNALS OF NUCLEAR MEDICINE

Superiority of 68Ga-FAPI PET/CT scan in detecting additional lesions compared to 18FDG PET/CT scan in breast cancer

(2021) Umut Elboga et al.   ANNALS OF NUCLEAR MEDICINE

Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

(2020) William J. Gradishar et al.   Journal of the National Comprehensive Cancer Network

Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer

(2020) J. Ristau et al.   MOLECULAR IMAGING AND BIOLOGY

Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer

(2018) David Groheux et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

(2018) Bernard Asselain et al.   LANCET ONCOLOGY

Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements

(2018) Mahsa Eskian et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

(2018) Gunter von Minckwitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

The accuracy of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review

(2017) Fangfang Tian et al.   EUROPEAN RADIOLOGY

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

(2017) Norikazu Masuda et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients

(2017) Laura Evangelista et al.   NUCLEAR MEDICINE COMMUNICATIONS

18F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials

(2016) David Groheux et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

18F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen

(2015) D. Groheux et al.   JOURNAL OF NUCLEAR MEDICINE

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

(2014) Patricia Cortazar et al.   LANCET

Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Monitoring the Response of Breast Cancer to Neoadjuvant Chemotherapy: A Meta–Analysis

(2013) Fabian Pius Mghanga et al.   Clinical Breast Cancer

High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis

(2013) Maria L. Wikberg et al.   TUMOR BIOLOGY